A study on thrombophilic factors in Italian Behcet's patients

被引:25
作者
Caramaschi, Paola [1 ]
Poli, Giovanni [2 ]
Bonora, Adriana [3 ]
Volpe, Alessandro [4 ]
Tinazzi, Ilaria [1 ]
Pieropan, Sara [1 ]
Bambara, Lisa M. [1 ]
Biasi, Domenico [1 ]
机构
[1] Policlin GB Rossi, Dipartimento Med Clin Sperimentale, I-37134 Verona, Italy
[2] Univ Verona, Dipartimento Sci Morfol Biomed, I-37100 Verona, Italy
[3] Univ Verona, Dipartimento Sci Neurol & Vis, I-37100 Verona, Italy
[4] Osped Negrar, Dipartimento Med Interna, Verona, Italy
关键词
Behcet's Disease; Vasculo-Behcet; Thrombophilic Factors; Thrombosis; FACTOR-V-LEIDEN; GENE G20210A MUTATIONS; PLASMA HOMOCYSTEINE LEVEL; VASCULAR INVOLVEMENT; COAGULATION PARAMETERS; FAMILIAL AGGREGATION; VENOUS THROMBOSIS; DISEASE; ASSOCIATION; HLA-B-ASTERISK-5101;
D O I
10.1016/j.jbspin.2010.02.022
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Behcet's disease (BD) may complicate with arterial and venous thrombosis. The purpose of this work is to evaluate in an Italian group of BD patients with thrombotic events a large panel of inherited and acquired thrombophilic factors. Methods: Thirty BD patients, of which nine with previously arterial or venous thrombosis and 21 without, underwent the following investigations: plasma antithrombin activity, protein C activity, free protein S level, sensitivity to APC, total plasma homocysteine concentration, serum folate level, determination of anti-phospholipid antibodies, serum Lp(a) levels, tests for gene polymorphisms of factor V Leiden, prothrombin and methylenetetrahydrofolate reductase genes. Tests for the gene polymorphisms were also performed in a group of healthy control subjects. Results: All the six patients with arterial or deep venous thrombosis showed thrombophilic conditions such as protein C or protein S deficiency (one case each), hyperhomocysteinemia (two cases), positivity of anti-phospholipid antibodies associated with APC resistance or hyperhomocysteinemia (one case each). Among three subjects with superficial thrombophlebitis only one showed a mild hyperhomocysteinemia. No differences were found between BD patients and control subjects concerning polymorphisms of the genes considered. Among BD patients the Factor V H1299R mutation showed a weak association with venous thrombosis (P = 0.048). Conclusion: In BD patients different concomitant significant thrombophilic risk factors may contribute to the development of thrombotic events. Patients affected by vasculo-Behcet should be evaluated for the presence of coexisting major thrombophilic conditions. (C) 2010 Societe francaise de rhumatologie. Published by Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:330 / 334
页数:5
相关论文
共 35 条
  • [11] Familial aggregation of Behcet's disease in Turkey
    Gül, A
    Inanç, M
    Öcal, L
    Aral, O
    Koniçe, M
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2000, 59 (08) : 622 - 625
  • [12] Gul A, 1996, BRIT J RHEUMATOL, V35, P1178
  • [13] Factor V Leiden mutation and PAI-1 gene 4G/5G genotype in thrombotic patients with Behcet's disease
    Gurgey, A
    Balta, G
    Boyvat, A
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 2003, 14 (02) : 121 - 124
  • [14] Gürgüz Ö, 2001, EUR J OPHTHALMOL, V11, P62
  • [15] Gurler Aysel, 1997, Yonsei Medical Journal, V38, P423
  • [16] Significant associations of HLA-B*5101 and B*5108, and lack of association of class II alleles with Behcet's disease in Italian patients
    Kera, J
    Mizuki, N
    Ota, M
    Katsuyama, Y
    Pivetti-Pezzi, P
    Ohno, S
    Inoko, H
    [J]. TISSUE ANTIGENS, 1999, 54 (06): : 565 - 571
  • [17] The vascular manifestations of Behcet's disease: angiographic and CT findings
    Ko, GY
    Byun, JY
    Choi, BG
    Cho, SH
    [J]. BRITISH JOURNAL OF RADIOLOGY, 2000, 73 (876) : 1270 - 1274
  • [18] KOC Y, 1992, J RHEUMATOL, V19, P402
  • [19] Familial aggregation in Behcet's disease:: High frequency in siblings and parents of pediatric probands
    Koné-Paut, I
    Geisler, I
    Wechsler, B
    Ozen, S
    Ozdogan, H
    Rozenbaum, M
    Touitou, I
    [J]. JOURNAL OF PEDIATRICS, 1999, 135 (01) : 89 - 93
  • [20] Korkmaz C, 2002, CLIN EXP RHEUMATOL, V20, pS30